Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
17
ALBT Quote, Financials, Valuation and Earnings
Last price:
$1.41
Seasonality move
:
-3.48%
Day range:
$1.44 - $1.52
52-week range:
$1.21 - $11.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.41x
P/B ratio:
--
Volume:
16.9K
Avg. volume:
33.8K
1-year change:
-45.11%
Market cap:
$2.8M
Revenue:
$1.3M
EPS (TTM):
-$9.80
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Avalon GloboCare Corp. has -- downside to fair value with a price target of -- per share.
ALBT vs. S&P 500
-
Over the past 5 trading days, Avalon GloboCare Corp. has underperformed the S&P 500 by -1.66% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Avalon GloboCare Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Avalon GloboCare Corp. has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Avalon GloboCare Corp. reported revenues of $350.1K.
Earnings Growth
-
Avalon GloboCare Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Avalon GloboCare Corp. reported earnings per share of -$0.06.
Enterprise value:
22.3M
EV / Invested capital:
8.10x
Price / LTM sales:
2.41x
EV / EBIT:
--
EV / Revenue:
15.98x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-3.93x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$358.8K
Return On Assets:
-138.58%
Net Income Margin (TTM):
-1355.18%
Return On Equity:
-1719.05%
Return On Invested Capital:
-253.02%
Operating Margin:
-21.77%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.2M | $1.3M | $1.4M | $345.2K | $350.1K | |
| Gross Profit | $196.6K | $243.9K | $358.8K | $99.6K | $115.7K | |
| Operating Income | -$8.6M | -$3.8M | -$7.3M | -$822.1K | -$76.2K | |
| EBITDA | -$8.2M | -$3.5M | -$7M | -$746.5K | -$16.7K | |
| Diluted EPS | -$8.77 | -$3.03 | -$9.80 | -$1.82 | -$0.06 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1M | $4.3M | $738.9K | $1.4M | $2M | |
| Total Assets | $10.4M | $12.9M | $30M | $19.6M | $9.1M | |
| Current Liabilities | $4.5M | $3.3M | $6.7M | $12.3M | $13.6M | |
| Total Liabilities | $8.5M | $8.3M | $13.1M | $14.1M | $13.6M | |
| Total Equity | $1.9M | $4.6M | $16.8M | $5.4M | -$4.5M | |
| Total Debt | $4.5M | $4.6M | $8M | $8.7M | $7.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$7.4M | -$4.6M | -$5.7M | -$1.6M | -$1.5M | |
| Cash From Investing | -$8.7M | $2.4M | $946.4K | $30K | $593.1K | |
| Cash From Financing | $12.6M | $2.9M | $3.9M | $2.4M | $983.1K | |
| Free Cash Flow | -$7.4M | -$4.6M | -$5.7M | -$1.6M | -$1.5M | |
ALBT
Sector
Market Cap
$2.8M
$991.9M
Price % of 52-Week High
12.52%
85.05%
Dividend Yield
0%
2.45%
Shareholder Yield
-86.59%
3.12%
1-Year Price Total Return
-45.11%
-4.5%
Beta (5-Year)
-0.114
0.644
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.40
200-day SMA
Sell
Level
$3.21
Bollinger Bands (100)
Sell
Level
1.81 - 2.51
Chaikin Money Flow
Sell
Level
-81.5M
20-day SMA
Sell
Level
$1.61
Relative Strength Index (RSI14)
Sell
Level
38.12
ADX Line
Sell
Level
25.99
Williams %R
Neutral
Level
-62.8363
50-day SMA
Sell
Level
$1.99
MACD (12, 26)
Sell
Level
-0.19
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
149.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.8171)
Sell
CA Score
(Annual)
Level (-2.0231)
Buy
Beneish M-Score
(Annual)
Level (-3.5308)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (6.7433)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
Stock Forecast FAQ
In the current month, ALBT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALBT average analyst price target in the past 3 months is --.
-
Where Will Avalon GloboCare Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Avalon GloboCare Corp. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Avalon GloboCare Corp.?
Analysts are divided on their view about Avalon GloboCare Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Avalon GloboCare Corp. is a Sell and believe this share price will rise from its current level to --.
-
What Is Avalon GloboCare Corp.'s Price Target?
The price target for Avalon GloboCare Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ALBT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Avalon GloboCare Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ALBT?
You can purchase shares of Avalon GloboCare Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Avalon GloboCare Corp. shares.
-
What Is The Avalon GloboCare Corp. Share Price Today?
Avalon GloboCare Corp. was last trading at $1.41 per share. This represents the most recent stock quote for Avalon GloboCare Corp.. Yesterday, Avalon GloboCare Corp. closed at $1.46 per share.
-
How To Buy Avalon GloboCare Corp. Stock Online?
In order to purchase Avalon GloboCare Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ALBT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ALBT
Sector
P/E ratio
--
17.27x
PEG ratio
0.00x
0.05x
P/B ratio
--
0.81x
Price / LTM sales
2.41x
3.10x
Growth Metrics
ALBT
Sector
Revenue growth
1.43%
3.28%
Earnings growth
96.56%
10.27%
Revenue (5-year growth)
-2.92%
2.86%
Earnings forecast
--
$0.15
Profitability
ALBT
Sector
Profitability FY 2024
$267.8K
$155.1M
Return on invested capital
-253.02%
2.04%
Return on assets
-138.58%
1.83%
Return on equity
-1719.05%
3.53%
Earnings Date
Last Earnings Date
Dec
8
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
ALBT
Sector
Total cash
$333.9K
$75M
Short term investments
--
$11.9M
Total assets
$21M
$3.2B
Long term debt
$7.2M
$365.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.19% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
